Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐004)

Research output: Contribution to journalArticlepeer-review

Abstract

Following the submission of application EFSA-GMO-RX-004 under Regulation (EC) No1829/2003 from Bayer CropScience, the Panelon Genetically Modified Organisms of the European Food Safety Authority (GMO Panel) was asked to deliver a scientific risk assessment on the data submitted in the context of the renewal of authorisation application of the genetically modified (GM) herbicide-tolerant oilseed rape MS8, RF3 and MS8xRF3. The data received in the context of this renewal application contain post-market environmental monitoring reports, systematic searches and evaluation of literature, updated bioinformatics analyses, and additional documents or studies performed by or on behalf of the applicant. The GMO Panelassessed these data for possible new hazards, modified exposure or new scientific uncertainties identified during the authorisation period and not previously assessed in the context of the original application. Under the assumption that the DNA sequence of the event in oilseed rape MS8, RF3 and MS8xRF3 considered for renewed authorisation is identical to the sequence of the originally assessed event, the GMO Panelconcludes that there is no evidence in the context of this renewal application for new hazards, modified exposure or scientific uncertainties that would change the conclusions of the original risk assessment on oilseed rape MS8, RF3 and MS8xRF3. (C) 2017 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Original languageEnglish
Number of pages12
JournalTHE EFSA JOURNAL
Volume15
Publication statusPublished - 2017

Fingerprint Dive into the research topics of 'Assessment of genetically modified oilseed rape MS8, RF3 and MS8×RF3 for renewal of authorisation under regulation (EC) No 1829/2003 (application EFSA‐GMO‐RX‐004)'. Together they form a unique fingerprint.

Cite this